(Q37168266)

18 August 2017

1 reference

title

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations (English)

1 reference

18 August 2017

1 reference

6

Federico Garrido

1 reference

18 August 2017

Natalia Aptsiauri

1

1 reference

18 August 2017

Rafael Carretero

2

1 reference

18 August 2017

Angel Garcia-Lora

3

1 reference

18 August 2017

Luis M Real

4

1 reference

18 August 2017

Teresa Cabrera

5

1 reference

18 August 2017

20 May 2008

1 reference

Cancer Immunology, Immunotherapy

18 August 2017

1 reference

18 August 2017

57

1 reference

18 August 2017

11

1 reference

18 August 2017

1727-1733

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-008-0532-3

18 August 2017

0 references

cites work

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0532-3

Crossref

reference URL

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0532-3

Crossref

reference URL

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0532-3

Crossref

reference URL

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35020115

Identifiers

DOI

10.1007/S00262-008-0532-3

1 reference

18 August 2017

1 reference